Back to All

Annual Diaceutics Report Illuminates State of Diagnostic Ecosystem in the Pharmaceutical Industry

14 December, 2016

Gain valuable insights into the state of the diagnostic ecosystem in the pharmaceutical industry with the annual Diaceutics report. This comprehensive analysis illuminates key trends, challenges, and opportunities shaping the landscape of diagnostic testing for precision medicine.

From examining the impact of regulatory changes to exploring emerging technologies and market dynamics, the report offers a holistic view of the diagnostic landscape. By understanding these insights, pharmaceutical companies, diagnostic laboratories, and healthcare providers can optimize their strategies and improve patient outcomes.

Explore the full report to stay informed about the evolving diagnostic ecosystem and discover how Diaceutics is leading the way in driving innovation and collaboration in precision medicine.

Click here to view the full article

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny